Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer
Clinical trial NCT02404506 · TERMINATED
Trial details
- NCT number
- NCT02404506
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-17
- Primary completion
- 2020-12-30
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.